161 related articles for article (PubMed ID: 36196779)
21. Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial.
Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
Ann Palliat Med; 2021 Feb; 10(2):2008-2017. PubMed ID: 33353357
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability.
Ahmed NA; Fouad EA; El-Asheer OM; Ghanem ASM
Front Pharmacol; 2024; 15():1391657. PubMed ID: 38873432
[No Abstract] [Full Text] [Related]
23. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
Umar RM; Apikoglu-Rabus S; Yumuk PF
Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
[TBL] [Abstract][Full Text] [Related]
24. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of drug-related problems and subsequent clinical pharmacists' interventions at a Swiss university hospital.
Reinau D; Furrer C; Stämpfli D; Bornand D; Meier CR
J Clin Pharm Ther; 2019 Dec; 44(6):924-931. PubMed ID: 31408206
[TBL] [Abstract][Full Text] [Related]
26. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.
Blix HS; Viktil KK; Moger TA; Reikvam A
Pharm World Sci; 2006 Jun; 28(3):152-8. PubMed ID: 17004023
[TBL] [Abstract][Full Text] [Related]
28. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial.
Bektay MY; Sancar M; Okyaltirik F; Durdu B; Izzettin FV
Front Pharmacol; 2022; 13():1049289. PubMed ID: 36703759
[No Abstract] [Full Text] [Related]
29. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
30. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
[TBL] [Abstract][Full Text] [Related]
31. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
Drugs Aging; 2011 Apr; 28(4):305-14. PubMed ID: 21428465
[TBL] [Abstract][Full Text] [Related]
32. Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic.
Ünder D; Enver C; Demirci MY; Ayhan YE; Özgan B; İlerler EE; Okuyan B; Ertürk Şengel B; Kocakaya D; Sili U; Tükenmez Tigen E; Karakurt S; Korten V; Sancar M
Turk J Pharm Sci; 2024 May; 21(2):152-158. PubMed ID: 38742835
[TBL] [Abstract][Full Text] [Related]
33. Determination of drug-related problems in the hematology service: a prospective interventional study.
Albayrak A; Özbalcı D
BMC Cancer; 2024 May; 24(1):552. PubMed ID: 38698336
[TBL] [Abstract][Full Text] [Related]
34. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.
Rodrigues JPV; Marques FA; Gonçalves AMRF; Campos MSA; Reis TMD; Morelo MRS; Fontoura A; Girolineto BMP; Souza HPMC; Cazarim MS; Maduro LCDS; Pereira LRL
PLoS One; 2019; 14(1):e0210779. PubMed ID: 30657771
[TBL] [Abstract][Full Text] [Related]
35. Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial.
AbuRuz S; Jaber D; Basheti I; Sadeq A; Arafat M; AlAhmad M; Said A
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e72-e78. PubMed ID: 32661104
[TBL] [Abstract][Full Text] [Related]
36. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
J Oncol Pharm Pract; 2021 Oct; 27(7):1644-1656. PubMed ID: 33040675
[TBL] [Abstract][Full Text] [Related]
37. Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.
Jermini M; Fonzo-Christe C; Blondon K; Milaire C; Stirnemann J; Bonnabry P; Guignard B
Int J Clin Pharm; 2024 Apr; 46(2):496-505. PubMed ID: 38315303
[TBL] [Abstract][Full Text] [Related]
38. Application of comprehensive pharmaceutical care program in identifying and addressing drug-related problems in hospitalized patients with osteoporosis.
Chen W; Zhang H; Jiang J; Zhang X; Ding J; Liu Y; Dang H
BMC Health Serv Res; 2022 Nov; 22(1):1438. PubMed ID: 36443812
[TBL] [Abstract][Full Text] [Related]
39. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital.
Lampert ML; Kraehenbuehl S; Hug BL
Pharm World Sci; 2008 Dec; 30(6):768-76. PubMed ID: 18357512
[TBL] [Abstract][Full Text] [Related]
40. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
